Pretreatment with exogenous IFN-β conferred resistance to HSV-1 infection in both AD and AR TBK1-deficient patients’ fibroblasts but not in IFNAR1-deficient fibroblasts (Fig. 3 D). This evidence concerns the gene TBK1 and Alzheimer disease.